Neurogene Cash Flow Statement (2018-2025) | NGNE

Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -14.57M-14.73M-4.83M-59.52M-8.36M-12.26M-11.86M-14.57M-13.97M-17.06M-18.63M-20.36M-19.66M-22.79M-23.23M-21.10M
Share-based Compensation 1.31M1.50M1.00M0.84M1.08M0.79M5.15M0.67M0.68M1.02M1.69M0.29M0.35M1.04M2.31M2.47M2.49M4.05M3.41M3.37M
Gains from Sales and Divestitures 0.01M0.01M0.04M
Gains from Investment Securities -0.13M0.20M-0.31M0.18M2.63M0.53M0.67M9.61M5.61M6.77M0.01M0.20M0.06M0.01M0.01M0.01M
Asset Writedowns and Impairment 0.10M0.09M
Non-cash Items 1.12M1.18M1.25M1.08M1.04M0.98M42.14M
Cash from Operations -15.59M9.18M-15.39M-9.78M-2.76M-1.47M-6.53M-4.64M-6.44M-13.60M-9.30M-11.60M-16.92M-21.70M-15.84M-15.56M-17.50M-20.80M-19.44M-19.51M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.02M0.03M0.02M0.11M0.53M0.01M0.01M0.01M0.08M0.45M0.02M0.01M0.96M1.75M0.01M0.01M
Amortization of Deferred Charges 0.02M0.03M0.02M0.53M0.00M0.25M
Depreciation & Amortization (CF) 0.04M0.04M0.10M0.16M0.17M0.81M0.80M0.80M0.85M0.81M0.80M0.80M0.79M0.75M0.80M0.80M
Change in Working Capital
Change in Account Payables 0.82M0.03M0.66M-0.84M0.14M0.23M-0.03M-0.42M1.69M-0.97M-0.50M
Change in Accured Expenses -1.63M3.96M-2.64M-6.16M-1.30M-2.50M-0.04M1.82M0.88M-2.44M1.16M1.38M-3.66M-4.88M0.21M2.64M-0.74M-2.20M2.17M0.36M
Investing Activities
Capital Expenditures 0.04M0.03M-0.02M0.78M0.11M0.03M0.08M0.08M0.13M0.14M0.38M0.18M0.10M0.78M0.15M0.13M
Change in Acquisitions & Divestments 30.00M23.00M3.00M5.00M30.00M19.50M8.75M15.75M44.70M68.00M99.50M
Cash from Investing Activities 29.96M22.97M3.02M-0.78M-0.11M-0.03M-0.08M-0.08M25.83M29.93M-23.61M-28.97M-102.62M-45.05M7.45M21.99M
Financing Activities
Other financing activities 0.10M1.86M-1.96M4.29M0.17M
Debt Issuance and Repayment
Long-Term Debt Repayments 0.00M0.00M0.02M0.00M0.00M0.00M0.00M0.00M0.00M
Change in Capital Stock
Shares Issued 0.20M0.40M81.00M3.39M0.11M0.02M0.04M92.18M0.63M0.41M0.14M188.40M0.02M0.07M9.71M
Misc.
Cash from Financing Activities 0.20M0.40M-0.02M-0.00M-0.00M-0.00M0.04M82.20M3.39M0.11M-0.09M-1.84M94.30M-6.52M0.40M0.13M190.06M0.00M0.05M9.71M
Exchange Rate Effect 0.01M-0.03M-0.00M-0.03M-0.00M0.00M0.01M0.00M-0.01M0.01M
Change in Cash 14.58M32.52M-12.40M-9.80M-2.76M-1.47M-6.39M76.79M-3.17M-13.48M-9.49M-13.49M103.16M1.76M-39.11M-44.40M69.95M-65.81M-11.96M12.19M
Beginning Cash Balance 52.03M66.61M99.13M86.73M76.93M74.17M72.70M66.31M142.59M129.60M201.15M48.97M40.60M38.71M45.05M148.38M150.14M111.03M66.63M136.59M70.77M58.81M
Free Cash Flow -15.63M9.15M-15.37M-9.78M-2.76M-1.47M-6.53M-5.42M-6.55M-13.63M-9.38M-11.68M-17.05M-21.84M-16.23M-15.74M-17.60M-21.58M-19.58M-19.64M
Net Cash Flow 14.57M32.55M-12.40M-9.78M-2.76M-1.47M-6.50M76.79M-3.16M-13.52M-9.47M-13.52M103.20M1.71M-39.06M-44.40M69.95M-65.84M-11.93M12.19M